MENU
+Compare
ADMA
Stock ticker: NASDAQ
AS OF
Sep 24, 04:59 PM (EDT)
Price
$15.67
Change
-$0.31 (-1.94%)
Capitalization
3.81B

ADMA ADMA Biologics Forecast, Technical & Fundamental Analysis

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases... Show more

Industry: #Biotechnology
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ADMA with price predictions
Sep 23, 2025

ADMA's RSI Indicator ascending out of oversold territory

The RSI Indicator for ADMA moved out of oversold territory on September 16, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In of the 23 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where ADMA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ADMA just turned positive on September 23, 2025. Looking at past instances where ADMA's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADMA advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

ADMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ADMA as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ADMA entered a downward trend on September 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.569) is normal, around the industry mean (19.924). P/E Ratio (18.800) is within average values for comparable stocks, (54.318). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.126). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (8.306) is also within normal values, averaging (347.892).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ADMA is expected to report earnings to rise 19.07% to 16 cents per share on November 05

ADMA Biologics ADMA Stock Earnings Reports
Q3'25
Est.
$0.17
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.31
Q3'24
Beat
by $0.02
The last earnings report on August 06 showed earnings per share of 14 cents, missing the estimate of 15 cents. With 840.93K shares outstanding, the current market capitalization sits at 3.81B.
A.I. Advisor
published General Information

General Information

an operator of a specialty immune globulin, development and commercialization of human plasma and plasma-derived therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
465 State Route 17
Phone
+1 201 478-5552
Employees
624
Web
https://www.admabiologics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSNRX43.860.50
+1.15%
Victory Global Energy Transition A
RYVFX10.84N/A
N/A
Royce Small-Cap Value Service
PACLX37.47-0.08
-0.21%
T. Rowe Price Capital Appreciation Adv
ROFRX14.77-0.04
-0.27%
Royce Small-Cap Opportunity R
CHTVX24.39-0.16
-0.65%
Invesco Charter R5

ADMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with IMTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-0.31%
IMTX - ADMA
41%
Loosely correlated
+3.94%
CPRX - ADMA
40%
Loosely correlated
-1.35%
IRON - ADMA
39%
Loosely correlated
+1.08%
RYTM - ADMA
39%
Loosely correlated
-0.30%
SYRE - ADMA
39%
Loosely correlated
+4.77%
More